Stabilization of Myopia–related Choroidal Neovascularization (CNV) with Classic Chinese Medicine Acupuncture after Anti-VEGF Failure: A Case Report

Pathologic myopia-related choroidal neovascularization (CNV) is a vision-threatening complication. Anti-vascular endothelial growth factor (VEGF) therapy is the current first-line treatment; however, some patients exhibit incomplete therapeutic response. This case report describes a middle-aged female with pathological myopia-related CNV who did not achieve stabilization after four intravitreal injections of bevacizumab (Avastin). Following an adjunctive course of classic Chinese medicine acupuncture consisting of 17 visits, optical coherence tomography (OCT) and fundus imaging demonstrated regression of exudation and stable visual acuity. This case highlights the potential role of classical Chinese medicine acupuncture in stabilizing myopic CNV when anti-VEGF therapy is insufficient and suggests a plausible integrative pathway for retinal microcirculation support.